Year archive

TransThera Sciences (Nanjing), Inc. — 2025 filings

All 40 regulatory filings released by TransThera Sciences (Nanjing), Inc. (2617) in 2025, sourced directly from the official regulator.

40 Filings

2025 Period

2025 filings (40)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2025-12-19	English
VOLUNTARY ANNOUNCEMENT PUBLICATION OF CLINICAL RESULTS OF OUR CORE PRODUCT TINENGOTINIB AGAINST CHOLANGIOCARCINOMA Regulatory Filings	2025-12-18	English
VOLUNTARY ANNOUNCEMENT PUBLICATION OF CLINICAL RESULTS OF OUR CORE PRODUCT TINENGOTINIB AGAINST CHOLANGIOCARCINOMA Regulatory Filings	2025-12-17	English
VOLUNTARY ANNOUNCEMENT INCLUSION OF TINENGOTINIB TABLETS IN THE LIST OF PRODUCTS FOR PRIORITY REVIEW BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2025-12-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-04	English
VOLUNTARY ANNOUNCEMENT COLLABORATION WITH NEUROCRINE Regulatory Filings	2025-11-03	English
INSIDE INFORMATION ANNOUNCEMENT PROPOSED IMPLEMENTATION OF THE H SHARE FULL CIRCULATION BY THE COMPANY Share Issue/Capital Change	2025-10-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-03	English
INTERIM REPORT 2025 Interim / Quarterly Report H1 2025	2025-09-19	English
VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS Regulatory Filings	2025-09-16	English
VOLUNTARY ANNOUNCEMENT PHASE II IND APPROVAL OF TINENGOTINIB IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF PREVIOUSLY TREATED HR+/HER2 NEGATIVE OR LOW EXPRESSION RELAPSED OR METASTATIC BRE Regulatory Filings	2025-09-10	English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE II CLINICAL TRIAL OF TINENGOTINIB IN COMBINATION WITH AKESO'S (CADONILIMAB, PD-1/CTLA-4) / (IVONESCIMAB, PD-1/VEGF) Regulatory Filings	2025-09-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-02	English
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY AS A CONSTITUENT OF THE HANG SENG INDEX SERIES Regulatory Filings	2025-08-25	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 Interim / Quarterly Report H1 2025	2025-08-25	English
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG Regulatory Filings	2025-08-25	English
DATE OF BOARD MEETING Regulatory Filings	2025-08-13	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 4 AUGUST 2025 Declaration of Voting Results & Voting Rights Announcements	2025-08-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Regulatory Filings	2025-08-04	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, 4 AUGUST 2025 Proxy Solicitation & Information Statement	2025-07-11	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-07-11	English
CIRCULAR OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-07-11	English
New Arrangements on Dissemination of Corporate Communications to Registered Shareholders Regulatory Filings	2025-07-10	English
New Arrangements on Dissemination of Corporate Communications to Non-Registered Shareholders Regulatory Filings	2025-07-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-07	English
VOLUNTARY ANNOUNCEMENT GRANT OF TINENGOTINIB (TT-00420) FAST TRACK DESIGNATION FOR TREATMENT OF MCRPC Regulatory Filings	2025-06-24	English
CLARIFICATION ANNOUNCEMENT Share Issue/Capital Change	2025-06-22	English
ANNOUNCEMENT OF ALLOTMENT RESULTS Share Issue/Capital Change	2025-06-20	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-06-20	English
Terms of Reference of the Strategy Committee of the Board of Directors Governance Information	2025-06-20	English
Terms of Reference of the Nomination Committee of the Board of Directors Governance Information	2025-06-20	English
Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors Governance Information	2025-06-20	English
Terms of Reference of the Audit Committee of the Board of Directors Governance Information	2025-06-20	English
Articles of Association Governance Information	2025-06-20	English
Documents on Display Regulatory Filings	2025-06-13	English
GLOBAL OFFERING Share Issue/Capital Change	2025-06-13	English
GLOBAL OFFERING Share Issue/Capital Change	2025-06-13	English
PHIP (1st submission) Regulatory Filings	2025-06-09	English
PHIP (1st submission) Audit Report / Information FY 2024	2025-06-09	English